期刊文献+

半乳凝集素-3与心房纤颤患者心肌纤维化的相关性研究 被引量:14

下载PDF
导出
摘要 目的:研究半乳凝集素-3(Galectin-3,Gal-3)与心房纤颤(AF)患者心肌纤维化的相关性。方法:选取在我院诊断的AF患者30例为试验组,同期在我院健康体检者30例为对照组;用酶联免疫吸附法(ELISA)检测患者Gal-3浓度与Ⅲ型前胶原氨基端肽(PⅢNP)、Ⅰ型前胶原羧基端肽(PⅠCP)、基质金属蛋白酶-2(MMP-2)浓度,并测量患者的左心室射血分数(LVEF),比较两组各值的差异,并分别对Gal-3与其他指标进行相关性分析。结果:试验组血浆Gal-3、PⅢNP、PⅠCP、MMP-2水平明显高于照组[Gal-3(57.21±9.08)pg/m L vs.(48.71±4.92)pg/m L;PⅢNP(1 681.78±142.54)pg/m L vs.(1 340.92±107.01)pg/m L;PⅠCP(29.64±3.24)μg/L vs.(22.21±2.42)μg/L;MMP-2(356.54±51.32)ng/m L vs.(308.06±30.58)ng/m L],差异有统计学意义(P<0.05)。试验组中Gal-3与PⅠCP及MMP-2呈明显正相关,差异有统计学意义(P<0.05),但Gal-3与PⅢNP无明显相关性(P=0.063);对照组中Gal-3与PⅠCP、PⅢNP、MMP-2均没有相关性。结论 :在AF患者中,心肌纤维化较正常对照组明显,且Gal-3与心房纤颤患者的心肌纤维化有相关性。
作者 刘璀 董剑廷
出处 《实用医学杂志》 CAS 北大核心 2015年第14期2322-2325,共4页 The Journal of Practical Medicine
  • 相关文献

参考文献2

二级参考文献33

  • 1KANNEL W B, BENJAMIN E J. Current perceptions of the epidemiology of atrial fibrillation [J]. Cardiol Clin, 2009,27 (1): 13-24.
  • 2LIP G Y, BRECHIN C M, LANE D A. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe[J]. Chest, 2012,142(6) : 1489-1498.
  • 3KANNEL W B, ABBOTT R D, SAVAGE D D, et al. Coronary artery disease and atrial fibrillation. The Framingham Study[J]. Am Heart J, 1983,106(2) : 389-396.
  • 4GAGE B F, WATERMAN A D, SHANNON W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation [J]. lAMA, 2001, 285(22): 2864-2870.
  • 5LIP G Y, NIEUWLAAT R, PISTERS R, et al. Refining clinical risk stratification for predicting stroke and thromb- oembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation [J]. Chest, 2010, 137(2): 263-272.
  • 6KANNEL W B, ABBOTT R D, SAVAGE D D, et al. Epidemi- ologie features of chronic atrial fibrillation :the Framingham study[J]. N Engl J Med, 1982, 306(17) : 1018-1022.
  • 7CHUGH S S, BLACKSHEAR J L, SHEN W K, et al. Epidemi- ology and natural history of atrial fibrillation: clinical implications [J]. J Am Coil Cardiol, 2001, 37(2) : 371-378.
  • 8WANG T J, LARSON M G, LEVY D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death [J]. N Engl J Med, 2004, 350(7) : 655-663.
  • 9KISTORP C, RAYMOND I, PEDERSEN F, et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults [J]. JAMA, 2005, 293 (13) : 1609- 1616.
  • 10NAKAMURA M, TANAKA F, ONODA T, et al. Gender- specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortalityin the Japanese general population [J]. Int J Cardiol, 2010, 143(2) : 124-129.

共引文献10

同被引文献102

引证文献14

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部